<html>
<head>PUBMED IDs for AVSD</head>
<body bgcolor='#C5F0F2'><h1>AVSD</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8250042/'>A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21.</a> December 1  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/9483642/'>Prenatal diagnosis of a terminal short arm deletion of chromosome 8 in a fetus with an atrioventricular septal defect.</a> March 4  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10922384/'>Detailed mapping of a congenital heart disease gene in chromosome 3p25.</a> August 3  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10922382/'>RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.</a> August 3  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11376440/'>Genetic aspects of atrioventricular septal defects.</a> May 29  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12632326/'>Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects.</a> March 13  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14613310/'>Collagen type VI expression during cardiac development and in human fetuses with trisomy 21.</a> November 13  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15161646/'>Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations.</a> May 27  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15221798/'>TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts.</a> June 29  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15917268/'>Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system.</a> May 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16919896/'>CRELD2: gene mapping, alternate splicing, and comparative genomic identification of the promoter region.</a> August 22  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17023674/'>The matricellular protein CCN1 is essential for cardiac development.</a> October 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17023672/'>TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study.</a> October 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19760623/'>Microarray based analysis of 3p25-p26 deletions (3p- syndrome).</a> December 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20718043/'>Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome.</a> January 15  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21337694/'>Descriptive study of nonsyndromic atrioventricular septal defects in the National Birth Defects Prevention Study, 1997-2005.</a> August 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22912673/'>Molecular signatures of cardiac defects in Down syndrome lymphoblastoid cell lines suggest altered ciliome and Hedgehog pathways.</a> April 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22912672/'>Interaction between smoking and HLA-DRB1*04 gene is associated with a high cardiovascular risk in Brazilian Amazon patients with rheumatoid arthritis.</a> April 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22987595/'>Polymorphic haplotypes of CRELD1 differentially predispose Down syndrome and euploids individuals to atrioventricular septal defect.</a> June 25  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23040494/'>An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects.</a> March 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23766104/'>Genetic abnormalities in FOXP1 are associated with congenital heart defects.</a> March 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23783273/'>The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376681/'>Transcriptional defect of an inherited NKX2-5 haplotype comprising a SNP, a nonsynonymous and a synonymous mutation, associated with human congenital heart disease.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376677/'>Distinct clinical outcomes of non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) mutations treated with EGFR tyrosine kinase inhibitors: non-responders versus responders.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376681/'>Transcriptional defect of an inherited NKX2-5 haplotype comprising a SNP, a nonsynonymous and a synonymous mutation, associated with human congenital heart disease.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376677/'>Distinct clinical outcomes of non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) mutations treated with EGFR tyrosine kinase inhibitors: non-responders versus responders.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24702954/'>Rare variants in NR2F2 cause congenital heart defects in humans.</a> May 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25356765/'>Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation.</a> July 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25524324/'>Germline mutations in NKX2-5, GATA4, and CRELD1 are rare in a Mexican sample of Down syndrome patients with endocardial cushion and septal heart defects.</a> December 19  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25524310/'>Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25524307/'>MicroRNAs in copy number variants in schizophrenia: misregulation of genome-wide gene expression programs.</a> August 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26062604/'>&quot;Down syndrome: an insight of the disease&quot;.</a> March 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26376067/'>A novel mutation of GATA4 (K300T) associated with familial atrial septal defect.</a> March 18  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26376054/'>Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.</a> March 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27058611/'>De Novo and Rare Variants at Multiple Loci Support the Oligogenic Origins of Atrioventricular Septal Heart Defects.</a> August 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27058589/'>Transcription Factor 7-Like 2 (TCF7L2) rs7903146 Polymorphism as a Risk Factor for Gestational Diabetes Mellitus: A Meta-Analysis.</a> August 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27064867/'>Detection and putative effect of GATA4 gene variants in patients with congenital cardiac septal defects.</a> February 2  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27340223/'>Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.</a> June 25  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27396555/'>Bioinformatic Analysis of Genes and MicroRNAs Associated With Atrioventricular Septal Defect in Down Syndrome Patients.</a>  2016   &gt; 0.5), pathway and functional enrichment analyses were performed using the online software DAVID (criterion: P &lt; 0.05). The protein-protein interaction (PPI) networks of DEGs were constructed based on the online server STRING (criterion: combined score &gt; 0.4). Next, miRNAs that targeted DEGs were predicted based on Webgestalt (criteria: P &lt; 0.05 and target DEGs â‰¥ 2), and miRNA-DEG regulatory networks were visualized through Cytoscape.A total of 179 DEGs were identified. Next, 5 functions and 1 pathway were enriched by up-regulated DEGs, while 4 functions were enriched by down-regulated DEGs. Furthermore, miRNA-DEG regulatory networks were constructed. IL1B was the hub-gene of PPI networks, and AUTS2 and KIAA2022 were predicted to be targeted by miR-518a, miR518e, miR-518f, miR-528a, and miR-96.IL1B, IL12RB2, AUTS2, and KIAA2022 might participate in AVSD in DS patients, and AUTS2 and KIAA2022 might be targeted by miR-518a, miR-518e, miR-518f, miR-528a, and miR-96. The identified genes and miRNAs might provide a theoretical basis for understanding AVSD in DS patients.<br><a href='https://pubmed.ncbi.nlm.nih.gov/28167794/'>Gata4 potentiates second heart field proliferation and Hedgehog signaling for cardiac septation.</a> February 8  2017<br></body></html>
